Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3
Open Access
- 1 November 2013
- journal article
- Published by Informa UK Limited in International Journal of Nanomedicine
- Vol. 8 (1), 4303-4314
- https://doi.org/10.2147/ijn.s50070
Abstract
The interaction between silver nanoparticles and viruses is attracting great interest due to the potential antiviral activity of these particles, and is the subject of much research effort in the treatment of infectious diseases. In this work, we demonstrate that silver nanoparticles undergo a size-dependent interaction with herpes simplex virus types 1 and 2 and with human parainfluenza virus type 3. We show that production of silver nanoparticles from different fungi is feasible, and their antiviral activity is dependent on the production system used. Silver nanoparticles are capable of reducing viral infectivity, probably by blocking interaction of the virus with the cell, which might depend on the size and zeta potential of the silver nanoparticles. Smaller-sized nanoparticles were able to inhibit the infectivity of the viruses analyzed.Keywords
This publication has 23 references indexed in Scilit:
- Nanoparticle Tracking Analysis for the Multiparameter Characterization and Counting of Nanoparticle SuspensionsPublished by Springer Science and Business Media LLC ,2012
- Paramyxovirus Fusion and Entry: Multiple Paths to a Common EndViruses, 2012
- Fungus-Mediated Green Synthesis of Silver Nanoparticles Using Aspergillus terreusInternational Journal of Molecular Sciences, 2011
- Silver Nanoparticles as Potential Antiviral AgentsMolecules, 2011
- Interaction of silver nanoparticles with Tacaribe virusJournal of Nanobiotechnology, 2010
- Mechanisms of viral emergenceVeterinary Research, 2010
- Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus NeuraminidasesPLOS ONE, 2009
- Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazoleNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivityPeptides, 2008
- Emerging foodborne pathogensInternational Journal of Food Microbiology, 2002